Tango Therapeutics, Inc. (TNGX)
26.64
+1.60
(+6.39%)
USD |
NASDAQ |
Apr 17, 16:00
26.81
+0.17
(+0.64%)
After-Hours: 20:00
Tango Therapeutics SG&A Expense (Quarterly) : 9.763M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 66.68M |
| Kodiak Sciences, Inc. | 11.96M |
| Hims & Hers Health, Inc. | 314.21M |
| Recursion Pharmaceuticals, Inc. | 33.66M |
| Terns Pharmaceuticals, Inc. | 8.699M |